MOLECULAR BIOLOGY AND DRUG THERAPIES OF CHRONIC MYELOID LEUKEMIA: A REVIEW OF RECENT LITERATURE
Background: Chronic myeloid leukaemia (CML) is a clonal myeloproliferative disorder of blood stem cells, which is typically characterized by the presence of a Philadelphia chromosome. Even though there have been several studies on the molecular genetics, pharmacogenomics, pharmacological treatments...
Saved in:
Main Authors: | Sameen Shahid, Muhammad Farooq Sabar, Zafar Iqbal, Muhammad Zafar Saleem, Muhammad Abbas Khokhar, Sana Ashiq |
---|---|
Format: | Article |
Language: | English |
Published: |
Superior University Lahore, Pakistan
2024-03-01
|
Series: | International Journal of Pharmacy & Integrated Health Sciences |
Subjects: | |
Online Access: | https://ijpihs.pk/index.php/IJPIHS/article/view/121 |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
COVID-19 PANDEMIC AND CHRONIC MYELOID LEUKEMIA: A REVIEW
by: Hafiza Sidra Bashir, et al.
Published: (2022-10-01) -
Key principles of drug therapy in patients with chronic myeloid leukemia
by: A. V. Zhuravlev, et al.
Published: (2023-07-01) -
MUTATION ANALYSIS FOR NUCLEOPHOSMIN-1 (NPM1) GENE VARIANT OF CHRONIC MYELOID LEUKEMIA PATIENTS FROM LAHORE-PAKISTAN
by: Sumaira Mehboob, et al.
Published: (2025-03-01) -
Inflammatory/Immune Adverse Events in Chronic Myeloid Leukemia Patients During Treatment With Bosutinib
by: E. Agostani, et al.
Published: (2025-02-01) -
Evaluation of Electrolytes Disturbances in Iraqi Chronic Myeloid Leukemia Patients treated with Nilotinib with Monitoring of Response by FISH Study
by: Baghdad Science Journal
Published: (2015-03-01)